T/LTIA 12-2021 Collection, storage, transportation, and inactivation methods for clinical samples of COVID-19
T/LTIA 12-2021 Collection, storage, transportation, and inactivation methods for clinical samples of COVID-19
Basic Information
Scope
Scope: This document specifies the applicable sample scope, biosafety requirements, sample collection, storage, transportation, reception, inactivation, and management requirements for the clinical diagnosis of novel coronavirus pneumonia. This document is applicable to relevant institutions such as disease control institutions at all levels, medical institutions, and third-party testing institutions engaged in novel coronavirus detection. Main technical content: 2.1 Defines the relevant terms for the collection, storage, transportation, and inactivation of clinical samples for novel coronavirus pneumonia; 2.2 Specifies the biosafety requirements for the collection, storage, transportation, and inactivation of clinical samples for novel coronavirus pneumonia; 2.3 Specifies the collection requirements for clinical samples for novel coronavirus pneumonia; 2.4 Specifies the storage requirements for clinical samples for novel coronavirus pneumonia; 2.5 Specifies the transportation requirements for clinical samples for novel coronavirus pneumonia; 2.6 Specifies the reception and inactivation requirements for clinical samples for novel coronavirus pneumonia; 2.7 Specifies the management requirements for clinical samples for novel coronavirus pneumonia.